David A. Bond, MD, BS¹, Ying Huang, MS, MA², John C. Reneau, MD, PhD³, Yazeed Sawalha, MD¹, Jonathan E. Brammer¹, Timothy Voorhees, MD, MSc¹, Narendranath Epperla, MD, MS⁴, Audrey M. Sigmund, MD¹, Lapo Alinari, MD, Ph.D⁵, Walter Hanel, MD, PhD⁶, Anna Gilmore^7*, Misty Fleming^7*, Kathleen Stamper^7*, Robert Baiocchi, MD, PhD⁵, Beth Christian, MD¹ and Kami J. Maddocks, MD^8,9

¹Division of Hematology, The Ohio State University, Columbus, OH
²Division of Hematology, Department of Statistics, The Ohio State University Wexner Medical Center, Columbus, OH
³The James Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH
⁴Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
⁵James Comprehensive Cancer Center, The Ohio State University, Columbus, OH
⁶The James Cancer Center, The Ohio State University Wexner Medical Center, Dublin, OH
⁷Ohio State University James Cancer Center, Columbus, OH
⁸The Ohio State University Comprehensive Cancer Center, Columbus, OH
⁹The James Cancer Center, The Ohio State University, Columbus, OH

Georgios Pongas, MD^1*, Ngoc Toomey^2*, Isildinha Reis^3*, Jennifer R. Chapman-Fredricks, MD^4*, Yi Zhou^5*, Erik Guillen, MSc^6*, Eric Liu^7*, Gregoire Lauvau, PhD^8*, B. Hilda Ye^9* and Juan Carlos Ramos, MD^1,10

¹Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
²Sylvester Conprehensive Cancer Center, University of Miami, Miami
³Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami
⁴Department of Pathology and Laboratory Medicine, University of Miami Miller School of Medicine, Miami, FL
⁵Molecular Diagnostics Lab, Department of Pathology, University of Miami Miller School of Medicine, Miami, FL
⁶Albert Einstein College of Medicine, Bronx, NY
⁷Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY
⁸Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY
⁹Albert Einstein Collge of Medicine, Bronx, NY
¹⁰Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL

Katharine L. Lewis^1,2,3,4,5,6, Pratyush Giri, MBBS^7*, Tamara Marconi, MBBS, FRACP, FRCPA^8*, Piers Blombery, MBBS^9,10,11,12, Colm Keane, MD¹³, Nagendra Prasad Sungala, MBBS¹⁴, Tara Cochrane, MBBS, FRCPA, FRACP¹⁵, Chun Kei Kris Ma, BSc MBBS PhD FRACP FRCPA^16,17,18, Vinay Vanguru, MBBS, FRACP, FRCPA^19*, Kate Manos, MBBS^20*, Roslyn Francis, MBBS, FRACP, PhD^21,22*, Mannu Walia, PhD^23*, Julia Carlson, Bsc^23*, Belinda E Butcher, BSc(Hons), MBiostat, PhD, CMPP AStat^24* and Chan Y. Cheah, MBBS DMSc^{1,25,26,27,28,29,30}

¹Sir Charles Gairdner Hospital, Perth, Western Australia, Australia
²Sir Charles Gairdner Hospital, West Leederville, Australia
³Department of Haematology, Sir Charles Gairdner Hospital, Perth, Australia
⁴Division Medical School, University of Western Australia, Perth, Western Australia, Australia
⁵University of Western Australia, Perth, Western Australia, Australia
⁶Sir Charles Gairdner Hospital, Nedlands, Australia
⁷Royal Adelaide Hospital, Adelaide, Australia
⁸Eastern Health, Melbourne, Australia
⁹Royal Melbourne Hospital, Melbourne, Australia
¹⁰Molecular Haematology, Peter MacCallum Cancer Centre & Royal Melbourne Hospital, Melbourne, Australia
¹¹Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia
¹²Peter Maccallum Cancer Centre, East Melbourne, VIC, Australia
¹³Mater Research, University of Queensland, Translational Research Institute, Brisbane, Australia
¹⁴Liverpool Hospital, Liverpool, NSW, AUS
¹⁵Department of Haematology, Gold Coast University Hospital, Southport, QLD, Australia
¹⁶Department of Hematology, University of Sydney/Westmead Hospital, Camperdown, Australia
¹⁷Westmead Hospital, Westmead, NSW, Australia
¹⁸The University of Sydney, Camperdown, Australia
¹⁹Institute of Haematology, Royal Prince Alfred Hospital, NSW, Australia
²⁰Flinders Medical Centre, Bedford Park, AUS
²¹Dept of Nuclear Medicine, Sir Charles Gairdner Hospital, Perth, Australia
²²Medical School, University of Western Australia, Perth, Australia
²³Australasian Leukaemia and Lymphoma Group, Melbourne, Australia
²⁴WriteSource Medical Pty Ltd, Lane Cove, NSW, Australia
²⁵Medical School, University of Western Australia, Crawley, Western Australia, Australia
²⁶Linear Clinical Research and Sir Charles Gairdner Hospital, Perth, Western Australia, Australia
²⁷Medical School, The University of Western Australia, Perth, Australia
²⁸Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia
²⁹Medical School, University of Western Australia, Perth, Western Australia, Australia
³⁰Linear Clinical Research, Nedlands, Western Australia, Australia

Christopher Melani, MD¹, Rahul Lakhotia, MBBS¹, Stefania Pittaluga, MD, PhD^2*, James D. Phelan, PhD^1*, Jagan R. Muppidi, MD, PhD^3*, Max J Gordon, MD^1*, Yandan Yang, PhD^1*, Weihong Xu^1*, Theresa Davies-Hill^2*, Da Wei Huang, MD^1*, Craig J. Thomas, PhD^4*, Michele Ceribelli, PhD^4*, Frances A Tosto^4*, Anna M Juanitez, RN^1*, Amynah Pradhan, NP^1*, Candis Morrison, NP, PhD^1*, Atekelt Tadese, PA^1*, Allison P. Jacob, MSc⁵, Heidi Simmons, PhD⁵, Seth M. Steinberg, PhD^6*, Elaine S. Jaffe, MD⁷, Mark Roschewski, MD⁸, Louis M. Staudt, MD, PhD⁹ and Wyndham H Wilson, MD, PhD^1*

¹Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
²Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
³Lymphoid Malignancies Branch, National Institutes of Health, Bethesda, MD
⁴Division of Pre-Clinical Innovation Chemistry Technologies, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD
⁵Adaptive Biotechnologies, Seattle, WA
⁶National Cancer Institute, National Institutes of Health, Bethesda, MD
⁷Laboratory of Pathology, Clinical Center, National Cancer Institute, National Institutes of Health, Bethesda, MD
⁸National Cancer Institute, Bethesda, MD
⁹Metabolism Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD

Jia Li¹, Ou Bai, MD/PhD^2*, Yangzhi Zhao, MD/PhD^3*, Wei Guo, MD/PhD^3* and Xingtong Wang, MD/PhD³

¹Department of Hematology, The First Hospital of Jilin University, Changchun, NY, China
²The First Hospital of Jilin University, Changchun, China
³Department of Hematology, The First Hospital of Jilin University, Changchun, China

Disha Dalela, MBBS^1*, Rahul Lakhotia, MBBS¹, Christopher Melani, MD¹, Stefania Pittaluga, MD, PhD^2*, James D. Phelan, PhD^1*, Jagan R. Muppidi, MD, PhD^3*, Sarah Evans, RN^1*, Amynah Pradhan, NP^1*, Atekelt Tadese, PA^1*, Candis Morrison^1*, Seth M. Steinberg, PhD^4*, Elaine S. Jaffe, MD⁵, Louis M. Staudt, MD, PhD⁶, Wyndham H. Wilson, MD, PhD^1* and Mark Roschewski, MD⁷

¹Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
²Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
³Lymphoid Malignancies Branch, National Institutes of Health, Bethesda, MD
⁴National Cancer Institute, National Institutes of Health, Bethesda, MD
⁵Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Great Falls, VA
⁶Metabolism Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
⁷National Cancer Institute, Bethesda, MD

Jinhua Liang, PhD^1*, Hao-Rui Shen^1*, Hua Yin^1*, Jiazhu Wu^1*, Yue Li^1*, Li Wang^1*, Lintao Bi, MD, PhD², Weiwei Qin, M.D., PhD^3*, Jianyong Li, MD¹ and Xu Wei, MD, PhD¹

¹Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China
²Department of Hematology, THE THIRD BETHUNE HOSPITAL OF JILIN UNIVERSITY, Changchun, China
³Department of Hematology, Tangdu hospital, Xi'An, China

Emmanuel Bachy, MD, PhD¹, Peter Trask^2*, Franck Morschhauser, MD, PhD³, Paolo Corradini, MD⁴, Shang-Ju Wu, MD, PhD^5*, Nancy L. Bartlett, MD⁶, Estefania Mulvihill^7*, Fabiola Bene Tchaleu^2*, Linda Lundberg^7* and Carmelo Carlo-Stella, MD⁸

¹Centre Hospitalier Lyon Sud, Pierre-Bénite, France
²Genentech, Inc., South San Francisco, CA
³Hôpital Claude Huriez and CHU de Lille, Lille, France
⁴University of Milan and Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
⁵National Taiwan University Hospital, Taipei, Taiwan
⁶Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO
⁷F. Hoffmann-La Roche Ltd, Basel, Switzerland
⁸Humanitas University and IRCCS Humanitas Research Hospital, Milan, Italy

Danielle N Blunt, BMBS^1,2, Rosemary Harrup^3*, Gerlinda Amor^4*, Helen Christensen^4*, Sarah Finlayson^5*, Frank Lin^6*, David M Ross, MD, PhD, FRACP, FRCPA^2,7*, Julia Dobbins^8,9*, Anna Brown, PhD^2*, Hamish S Scott, PhD^2,10 and Steven W Lane, MBBS, PhD, FRCPA, FRACP¹¹

¹Royal Adelaide Hospital, Glenunga, Australia
²SA Pathology, Adelaide, SA, Australia
³Royal Hobart Hospital and University of Tasmania, Tasmania, Australia
⁴QIMR Berghofer Medical Research Institute, Brisbane, Australia
⁵University of Sydney, NHMRC Clinical Trials Centre, Sydney, Australia
⁶University of Sydney, NHMRC Clinical Trials Centre,, Sydney, Australia
⁷Royal Adelaide Hospital, Adelaide, SA, Australia
⁸Genetics and Molecular Pathology, SA Pathology, Adelaide, SA, Australia
⁹A SA Pathology and UniSA Alliance, Centre for Cancer Biology, Adelaide, Australia
¹⁰Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA, Australia
¹¹Cancer Program, QIMR Berghofer Medical Research Institute, Royal Brisbane and Women’s Hospital, Brisbane, QLD, Australia

Wei Wang^1*, Xu Zhang^2*, Qihui Li^3*, Hua Yin, MD^4*, Xiubin Xiao^4*, Jian Li, MD⁵, Wenrong Huang⁴, Hongmei Jing, MD² and Yan Zhang, MD^6*

¹Peking union medical college hospital, Beijing, China
²Department of Hematology, Lymphoma Research Center, Peking University Third Hospital, Beijing, China
³peking university third hospital, Beijing, China
⁴Lymphoma & Plasma Cell Disease Department of Hematology, the Fifth Medical Center of Chinese PLA General Hospital, Beijing, China
⁵Department of Hematology, Peking Union Medical College Hospital, Beijing, China
⁶Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China

Raphael Steiner, MD^1*, Liana Nikolaenko^2*, Swetha Kambhampati, MD², Niloufer Khan, MD³, Ranjit Nair, MD⁴, Jeremy S. Abramson, MD⁵, Steven Horwitz, MD¹, Matthew Matasar, MD, MS⁶, Colette Owens, MD¹, Ildefonso Ismael Rodriguez Rivera, MD^1,7*, David J. Straus, MD¹, Timothy S Pardee, MD, PhD⁸, Sanjeev Luther^9*, Win Su Thet, MBBS^1*, Shreya Vemuri, BSc, MPH^1* and Ariela Noy, MD¹

¹Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
²City of Hope National Medical Center, Duarte, CA
³City of Hope National Medical Center, New York, NY
⁴The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Massachusetts General Hospital Cancer Center, Boston, MA
⁶Lymphoma Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY
⁷Texas Oncology & New Experimental Therapeutics LLC, Irving, TX
⁸Wake Forest University, Winston-Salem, NC
⁹Cornerstone Pharmaceuticals, CRANBURY, NJ

Mutita Surakijboworn, MD^*, Noppachan Uaprasert, MD^* and Ponlapat Rojnuckarin, MD

Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand

Jean-Marie Michot^1*, Abhay Patki^2*, Marina Maglakelidze^3*, Regis Costello, MD, PhD^4*, Martin Donchev^5*, Vincent Ribrag, MD⁶ and Igori Vinogradov^7*

¹Gustave Roussy Cancer Campus, Villejuif, France
²INVOX Pharma, London, United Kingdom
³Arensia Tbilisi – PPDS, Georgia, Tbilisi, Georgia
⁴Hematology, AP-HM, Marseille, France
⁵Specialized Hospital for Active Treatment of Haematological Diseases – Sofia, Bulgaria, Sofia, Bulgaria
⁶Département d'Innovation Thérapeutique et d'Essais Précoces (DITEP), Gustave Roussy Institute of Cancer, Villejuif, France
⁷IMSP Institute of Oncology, Moldova, Chișinău, Moldova, The Republic of

Jie Zou^1*, Xiaoning Yu^1*, Xiaoxia Chu^2*, Ji Ma^3*, Zengjun Li^4*, Chunyan Chen^5*, Yan Liu^6*, Jian Xing^7*, Zhongliang Sun^8*, Chunyan Ji⁹ and Jie Li^1*

¹Hematology and Oncology Unit, Department of Geriatrics, Qilu Hospital, Shandong University, Jinan, CHN
²The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, China
³Department of Hematology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China
⁴Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Ji'nan, China
⁵Qilu Hospital of Shandong University, Jinan, China
⁶Hematology Department, ZIBO CENTRAL HOSPITAL, Zibo, China
⁷SHENGLI Oilfield Central Hospital, Dongying, China
⁸The First People's Hospital of Jining City, Jining City , Shandong Province, China
⁹Department of Hematology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China

Jianai Sun^1*, Yi Xu^2*, Huafeng Wang^3*, Xiaolong Zheng^4*, Wenjuan Yu^5*, De Zhou^1*, Chunmei Yang^3*, Xinping Zhou^1*, Liping Mao, M.D.^6*, Haitao Meng^1*, Liangshun You, MD^1*, Min Yang, M.D.^3*, Hongyan Tong, PhD⁷, Jie Jin, M.D.¹ and Wanzhuo Xie, M.D.^7*

¹Department of Hematology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
²First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
³Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
⁴Zhejiang Provincial Clinical Research Center For Hematological disorders, Hangzhou, China
⁵Zhejiang University Cancer Center, Hangzhou, China
⁶Zhejiang Provincial Key Laboratory of Hematopoietic Malignancy, Zhejiang University, Hangzhou, China
⁷Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

Neha Dixit, PhD¹, Binhuan Wang^2*, Kevin Zhao^3*, Catherine Thieblemont^4*, Irit Avivi Mazza^5,6*, David Lavie^7*, Abraham Avigdor, MD⁸, Carlos Grande Garcia^9*, Andrew J. Steele, PhD^10*, Mostafa Seliem, PharmD^1*, Pegah Jafarinasabian, MD, PhD^1* and Edith Szafer Glusman, PhD^1*

¹AbbVie Inc, North Chicago, IL
²AbbVie, Inc, South San Francisco, CA
³AbbVie Inc, South San Francisco, CA
⁴Assistance Publique & Hôpitaux de Paris (APHP), Hôpital Saint-Louis, Hémato-oncologie, Université de Paris, Paris, FRA
⁵Hematology Division, Sourasky Medical Center and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
⁶Hematology Division, Sourasky Medical Center and the Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
⁷Department of Hematology, Hadassah Medical Center, Jerusalem, Israel
⁸Sheba Medical Center, Ramat Gan and Tel Aviv University, Tel Aviv, Israel
⁹Clínica Universidad de Navarra, Madrid, Spain
¹⁰Genmab, Plainsboro, NJ

Lijuan Deng^1*, Tianheng He^2*, Yongjing Tang^3*, Lan Mi^4*, Changyu Lu^5*, Hanxiao Liu^2*, Shupeng Zhong^1*, Jin Chai^1*, Jun Luo, MD^6*, Liling Zhang^7*, Shujuan Wen^8*, Xiaopei Wang^1*, Jun Zhu, PhD⁹ and Yuqin Song^10*

¹Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, China
²Department of lymphoma, Peking University International Hospital, Beijing, China
³Department of lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, China
⁴Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute, Beijing, China
⁵Department of neurosurgery, Peking University International Hospital, Beijing, China
⁶Department of Haematology, THE FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY, Nanning, China
⁷Department of lymphoma, Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
⁸Department of lymphoma, The Affiliated Cancer Hospital of Xinjiang Medical University, Urumqi, China
⁹Department of Lymphoma, Peking University Cancer Hospital, Beijing, Beijing, China
¹⁰Department of Lymphoma,, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, China

Liling Zhang^1*, Qiuhui Li^1*, Fang Zhu^1*, Gang Wu^1*, Xiaona Chang^2*, Huaxiong Pan^2*, Tao Liu^1* and Xinxiu Liu^1*

¹Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
²Department of Pathology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

Yasmin H. Karimi, MD¹, Michael Roost Clausen, MD, PhD^2*, David John Lewis, MD^3*, Wojciech Jurczak, MD, PhD⁴, Michelle Poon, MBBS, MRCP^5*, Tae Min Kim, MD, PhD^6*, Young Rok Do, MD, PhD⁷, Pieternella Lugtenburg, MD, PhD⁸, Kristin Conte, MPH^9*, David Soong, PhD^10*, Barbara D'Angelo Månsson, PhD^11*, Zhu Li, MS^10*, Christian Eskelund, MD, PhD^10* and Martin Hutchings, MD, PhD¹²

¹Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI
²Vejle Hospital, Vejle, Denmark
³University Hospitals Plymouth NHS Trust, Plymouth, United Kingdom
⁴MSC National Research Institute of Oncology, Kraków, Poland
⁵Department of Haematology-Oncology, National University Cancer Institute, National University Health System, Singapore, Singapore
⁶Seoul National University Hospital, Seoul, Korea, Republic of (South)
⁷Keimyung University Dongsan Medical Center, Daegu, Korea, Republic of (South)
⁸On behalf of the Lunenburg Lymphoma Phase I/II Consortium-HOVON/LLPC, Erasmus MC Cancer Institute, University Medical Center, Department of Hematology, Rotterdam, Netherlands
⁹AbbVie, North Chicago, IL
¹⁰Genmab, Plainsboro, NJ
¹¹Genmab, Copenhagen, Denmark
¹²Rigshospitalet and University of Copenhagen, Copenhagen, Denmark

Lalita Norasetthada, MD¹, Joaquin Diaz^2*, Fangfang Lv^3*, Yuqin Song, MD⁴, Seung Tae Lee, MD, PhD⁵, Ewa Paszkiewicz-Kozik, MD, PhD^6*, Dipenkumar Modi, MD⁷, Armando Santoro, MD^8*, Kumudu Pathiraja^9*, Nishitha Reddy⁹, Rushdia Yusuf⁹ and Muhit Ozcan, MD¹⁰

¹Chiang Mai University, Chiang mai, Thailand
²Clínica Alemana, Santiago, Chile
³Fudan University Shanghai Cancer Center, Shanghai, China
⁴Department of Lymphoma, Peking University Cancer Hospital, BEIJING, China
⁵University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD
⁶Maria Sklodowska–Curie National Research Institute of Oncology, Warsaw, Poland
⁷Barbara Ann Karmanos Cancer Institute, Detroit, MI
⁸Humanitas University, Pieve Emanuele and IRCCS Humanitas Research Hospital-Humanitas Cancer Center Rozzano, Milan, Italy
⁹Merck & Co., Inc., Rahway, NJ
¹⁰Hematology Department, Ankara University School of Medicine, Cankaya-Ankara, Turkey

Yuqin Song, MD¹, Jian Zhang^2*, Keshu Zhou^3*, Liling Zhang^4*, Minal Barve^5*, Charlotte Lemech^6,7*, Wenyu Li^8*, Hua-Jay J. Cherng, MD^9*, He Huang^10*, Linna Xie, MD, PhD^11*, Richard Zuniga^12*, Caicun Zhou^13*, Lin Shen^14*, Shujun Yang^3*, Sarwan Bishnoi^15*, Yan Zhang^11*, Jingru Wang^16*, Xiaoli Zhu^16*, Fei Li^16* and Jason Yang^16*

¹Department of Lymphoma, Peking University Cancer Hospital, BEIJING, China
²Shanghai Cancer Hospital of Fudan University, Shanghai, China
³Henan Cancer Hospital, Zhengzhou University, Zhengzhou, China
⁴Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
⁵Mary Crowley Cancer Research, Dallas Texas
⁶Scientia Clinical Research Limited, Sydney, Australia
⁷Prince of Wales Hospital Clinical School, Sydney, Australia
⁸Guangdong Provincial People's Hospital, Guangzhou, China
⁹Columbia University Irving Medical Center, New York
¹⁰The First affiliated hospital, Zhejiang University School of Medicine, Hangzhou, China
¹¹Shandong First Medical University (Shandong Academy Of Medical Sciences), Jinan, China
¹²New York Cancer and Blood Specialists, New York
¹³Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China
¹⁴State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translationa lResearch, Peking University Cancer Hospital & Institute, Beijing, China
¹⁵ICON Cancer Centre, Adelaide, Australia
¹⁶CStone Pharmaceuticals Co., Ltd., Shanghai, China

Xiaolei Wei, MD^1*, Xutao Guo, MD^2*, Qi Wei, MD^3*, Dan Xiong, MD & PhD^4*, Peng Zhang^5*, Zewen Zhang^6*, Yongqiang Wei, MD^1* and Ru Feng^7*

¹Department of Hematology, Nanfang Hospital of Southern Medical University, Guangzhou, China
²Nanfang Hospital, GUANGZHOU, GUANGDONG, China
³Guangzhou Dadao North Street NO. 1838, Guangzhou, Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangzhou, China
⁴Department of Hematology, Shunde Hospital, Southern Medical University, Guangzhou, China
⁵Department of Hematology, General Hospital of Southern Theater Command, Guangzhou, China
⁶Department of Hematology, The Second Affiliated Hospital of Shantou University Medical College, Shantou, China
⁷Department of Hematology, Nanfang Hospital of Southern Medical University, Guangzhou, China, Guangdong, China

Lin Gui, MD^1*, Keshu Zhou^2*, Ting Liu³, Yan Qin, MD^4*, Hongmei Jing^5*, Wenyu Li, MD^6*, Yajun Li^7*, Wenrong Huang, MD^8*, Zhen Wang, MD^9*, Xiuhua Sun, MD^10*, Quan Li, MD^11*, Faming Zhang, PhD^12*, Henry Li, PhD^12*, Lei Zhang, MD^12*, Peng Sun, MD^12*, Xinbao Gao^12* and Yuankai Shi, MD^1*

¹Cancer Hospital (Institute), CAMS & PUMC, Beijing, China
²Department of Hematology, Henan Cancer Hospital, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China
³Department of Hematology, West China Hospital of Sichuan University, Chengdu, China
⁴Cancer Hospital Chinese Academy of Medical Sciences，Shenzhen Center, Shenzhen, China
⁵Department of Hematology, Peking University Third Hospital, Beijing, China
⁶Guangdong Provincial People's Hospital, Guangzhou, China
⁷Department of Lymphoma and Hematology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, China
⁸The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China
⁹Linyi Cancer Hospital, Linyi, China
¹⁰The Second Hospital of Dalian Medical University, Dalian, China
¹¹Xiangyang Central Hospital, Xiangyang, Hubei, China
¹²Hangzhou Hanx Biopharmaceuticals, Ltd., Hangzhou, China

Haichen Wei^1*, Lijie Xing^1*, Dan Liu^1*, Hui Wang^1*, Ping Li^1* and Zengjun Li^2*

¹Department of Lymphoma, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Ji'nan, Shandong, China
²Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Ji'nan, China